Nutrition in Cirrhosis

Malnutrition and muscle wasting (sarcopenia) affect 50–90% of patients with advanced cirrhosis, depending on the assessment method and population studied (EASL 2019; ESPEN 2019). Despite this prevalence, nutrition is frequently undertreated — partly because weight may appear preserved in patients with ascites, masking true lean body mass depletion.

The consequences are significant and well-documented:

Sarcopenia predicts mortality independently of MELD and Child-Pugh. In the landmark CT-based study, sarcopenia on L3 skeletal muscle index remained an independent predictor on multivariate analysis alongside CTP and MELD (Montano-Loza 2012, PMID 21893129) — which is why a patient can be "low MELD" and still high-risk.
Pre-transplant sarcopenia is associated with longer ICU stays, higher rates of infection, and worse long-term survival post-transplant
Hepatic encephalopathy is worsened by both protein deficiency and excess
Frailty predicts waitlist mortality and is now assessed formally at many transplant centres using the Liver Frailty Index (LFI). Adding the LFI to MELD-Na improved 3-month waitlist mortality prediction over MELD-Na alone (Lai 2017, PMID 28422306).

Multiple mechanisms converge:

Reduced intake: Early satiety from ascites, anorexia, dysgeusia (taste changes), nausea from medications
Malabsorption: Portal hypertensive enteropathy, bacterial overgrowth, cholestasis impairing fat-soluble vitamin absorption
Altered metabolism: Cirrhotics use fat as a preferential fuel substrate even in the fed state — they enter a "starvation-like" state more quickly than healthy individuals. Overnight fasting alone can cause significant catabolism.
Protein catabolism: Hormonal dysregulation, systemic inflammation, increased gluconeogenesis from muscle amino acids
Ascites management: Sodium restriction (often inappropriately also restricts calories) and diuretics

Standard measures (BMI, serum albumin) are unreliable in cirrhosis:

BMI is confounded by ascites and edema — body weight overestimates lean mass
Albumin reflects hepatic synthetic function, not nutritional status, in liver disease

Better tools include:

Royal Free Hospital-Global Assessment (RFH-GA): derived and validated specifically in cirrhosis; combines BMI, mid-arm muscle circumference, and dietary intake (Morgan 2006)
Handgrip strength: simple, reproducible, and predictive of clinical outcomes — in cirrhotic outpatients followed for a year it predicted major complications better than subjective global assessment (Alvares-da-Silva 2005, PMID 15723736)
Liver Frailty Index (LFI): a performance-based composite of exactly three measures — grip strength, timed chair stands, and balance testing. Note it does not include a walk test. Validated in cirrhosis and used at many transplant centres (Lai 2017).
6-minute walk test: a separate measure of functional capacity, also used pre-transplant but distinct from the LFI
CT-based sarcopenia assessment: Skeletal muscle index at L3 level on cross-sectional imaging — gold standard but not routinely ordered for nutritional purposes

ESPEN and EASL guidelines recommend:

Component	Target	Notes
Energy	≥35 kcal/kg/day (EASL; ESPEN 30–35)	Dry/ideal body weight in obesity; adjust for ascites
Protein	1.2–1.5 g/kg/day (dry weight)	Higher than historically taught; maintain even in HE
BCAAs	Supplement leucine, isoleucine, valine	Improves hepatic encephalopathy and may support muscle mass; a mortality benefit has NOT been demonstrated. Conditional recommendation (EASL 2019)
Late evening snack	~50 g carbohydrate before sleep	Reduces overnight fasting catabolism; improves nitrogen balance
Sodium	2 g/day (for ascites)	Do NOT conflate with calorie restriction — sodium ≠ food restriction

Do not restrict protein

Protein restriction is not recommended in cirrhosis and is actively harmful — it accelerates sarcopenia. Protein intake should be maintained even during hepatic encephalopathy; treat HE with lactulose/rifaximin and by removing precipitants, not by restricting protein.

Common and clinically significant:

Micronutrient	Consequence of deficiency	Note
Zinc	Contributes to HE and immune dysfunction	Deficiency is common; supplementation is suggested where deficiency is documented, though evidence for reducing HE is limited (EASL 2019)
Fat-soluble vitamins (A, D, E, K)	Impaired absorption in cholestatic disease	Vitamin D deficiency nearly universal; bone + immune effects
B vitamins (thiamine, folate, B12)	Thiamine deficiency → Wernicke encephalopathy	Critical in alcohol-related disease (see warning)
Magnesium, phosphorus	Common electrolyte deficiencies	Worsened by diuretic use

Thiamine with glucose

In alcohol-related disease, give thiamine before or at the same time as glucose — a glucose load in a thiamine-deficient patient can precipitate Wernicke encephalopathy. Never delay treatment of hypoglycaemia while waiting for thiamine: if the patient is hypoglycaemic, give glucose immediately and administer thiamine concurrently.

Refer to a registered dietitian with hepatology experience at first decompensation
Oral nutritional supplements (ONS) for patients unable to meet caloric needs by diet alone
Nasogastric tube feeding if oral intake is severely limited. ESPEN 2019 supports enteral tube feeding in cirrhosis — the presence of oesophageal varices is not in itself a contraindication, though it is avoided during active variceal haemorrhage
Exercise rehabilitation: resistance and combined exercise programmes improve muscle mass and functional status in compensated cirrhosis and are increasingly studied in transplant candidates (EASL 2019)

Clinical Application

A 58-year-old woman with MASH cirrhosis is being evaluated for transplant. Despite a preserved BMI, CT imaging shows severe sarcopenia. She reports eating only two small meals per day because of early satiety from her ascites.

MELD 3.0: 17 | BMI 28 | CT: skeletal muscle index consistent with severe sarcopenia

Work through the management step by step before the answers are revealed.